Ascensia Diabetes Care is a global company dedicated to improving the health and lives of people with diabetes. Formed in 2016 through the acquisition of Bayer Diabetes Care by PHC Holdings (formerly Panasonic Healthcare Holdings), Ascensia combines over 80 years of experience in diabetes care innovation. They are known for their world-renowned CONTOUR® portfolio of blood glucose monitoring (BGM) systems and also distribute the Eversense® Continuous Glucose Monitoring (CGM) System. Ascensia is committed to developing integrated digital solutions to empower individuals and healthcare professionals to manage diabetes more effectively.
The Basel headquarters serves as the central command for global strategy, research and development leadership, corporate governance, finance, and coordination of international market operations.
Located in a modern business district, the headquarters likely features contemporary office design, facilitating collaboration and innovation, with advanced communication infrastructure to support global operations.
The work culture is expected to be patient-focused, innovative, and collaborative, reflecting its mission in healthcare. Being in Switzerland, it likely emphasizes precision, quality, and a multinational professional environment.
Basel's strong life sciences ecosystem provides Ascensia with access to talent, research partnerships, and a network of industry peers, crucial for a company focused on medical technology innovation.
Ascensia Diabetes Care has a significant global footprint, with its products sold in more than 125 countries. Their worldwide operations encompass research and development, manufacturing oversight, regional sales and marketing offices, extensive distribution networks, and localized customer support. This global structure enables Ascensia to tailor its diabetes care solutions to diverse healthcare systems and patient needs across North America, Europe, Asia-Pacific, Latin America, and other regions.
Peter Merian-Strasse 90
Basel
Basel-Stadt
Switzerland
Address: 5 Wood Hollow Road, Parsippany, NJ 07054, USA
To manage and expand Ascensia's business in the United States and Canada, ensuring product availability, regulatory compliance, and tailored marketing initiatives for the North American diabetes care market.
Address: 2-38-5 Nishishimbashi, Minato-ku, Tokyo 105-8433, Japan (c/o PHC Corporation)
To leverage PHC Group's strengths in the Japanese market, manage regional distribution, and coordinate activities across Asia-Pacific, a growing market for diabetes care solutions.
Address: Parc Rez-de-Seine, 20-26 Quai du Point du Jour, 92100 Boulogne-Billancourt, France (Note: Location can vary, this is a common address for their French operations, verify if critical)
To drive Ascensia's business growth in France, managing local commercial activities, regulatory affairs, and customer engagement within the French healthcare system.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Ascensia Diabetes Care' leadership includes:
Ascensia Diabetes Care has been backed by several prominent investors over the years, including:
Ascensia Diabetes Care has seen some key leadership appointments in the past year, notably strengthening its regional leadership in the Americas. Other core global executive positions appear stable.
Discover the tools Ascensia Diabetes Care uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Ascensia Diabetes Care commonly uses the [first].[last]@ascensia.com email format. Other potential formats might include [first_initial][last]@ascensia.com.
[first].[last]@ascensia.com
Format
john.smith@ascensia.com
Example
80%
Success rate
LinkedIn / Company Announcement • January 9, 2024
Ascensia Diabetes Care announced the appointment of Amy Langan as the new Head of Region Americas. She will be responsible for leading the company's commercial strategy and operations across North and South America....more
Business Wire • October 10, 2023
Ascensia Diabetes Care launched an updated version of its CONTOUR®DIABETES app in the U.S., now featuring integrated connectivity with Senseonics’ Eversense® E3 Continuous Glucose Monitoring (CGM) System. This allows users to see their BGM and CGM data together in one app....more
Ascensia Diabetes Care Press Release • June 23, 2023
Ascensia Diabetes Care presented data and insights at the American Diabetes Association's (ADA) 83rd Scientific Sessions, emphasizing the role of its CONTOUR® portfolio and digital solutions in supporting personalized diabetes self-management....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Ascensia Diabetes Care, are just a search away.